Misoprostol for open myomectomy: a systematic review and meta-analysis of randomised control trials.

CONCLUSION: Moderate to high quality studies have established that misoprostol minimises blood loss and need for blood transfusion at open myomectomy. This low-cost and readily-available drug should be routinely administered prior to open myomectomy to improve clinical outcomes. PMID: 32613769 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32613769?dopt=Abstract

Source: BJOG : An International Journal of Obstetrics and Gynaecology - June 30, 2020 Category: OBGYN Authors: Wali S, Balfoussia D, Touqmatchi D, Quinn S Tags: BJOG Source Type: research